• About

    Featuring PASV Valve and Endexo technology, the BioFloTM PASV PICC is shown to reduce catheter occlusions by 78% 1 and thrombus accumulation by 87% 2. 1 Burns, D. Retrospective Analysis The Vanderbilt PICC service: Program, Program, Procedural and Patient Outcomes Success, Vanderbilt University. JAVA Vol.10 No. 42005 2 In vitro blood loop model test results demonstrated on average 87% less thrombus accumulation.   BioFlo is a trademark of AngioDynamics® and is distributed by Kimal PLC  in the UK and Germany.
  • Resources

Download a brochure